Search Results - Meera Mohan
- Showing 1 - 19 results of 19
-
1
-
2
-
3
Non-invasive brain stimulation as an experimental treatment approach for bulimia nervosa and binge eating disorders: A meta-analysis and systematic review of literature by Barath Ramanathan, Souganya Vijayan, Meera Mohan, Velprashanth Venkatesan, Arun Selvaraj, Perarul Sivakumar
Published in Indian Journal of Psychiatry (2026-05-01)Get full text
Article -
4
-
5
Gender disparities in multiple myeloma publications by Aala Dweik, Hadeel Dweik, Hira Mian, Meera Mohan, Carolina Schinke, Samer Al Hadidi
Published in eJHaem (2022-08-01)Get full text
Article -
6
Safety and efficacy of BCMA CAR-T <i>vs.</i> bispecific antibodies in patients with relapsed multiple myeloma: a systematic review and meta-analysis by Hayley Vandenboom, Othman Akhtar, Aniko Szabo, Ravi Narra, Meera Mohan, Anita D’Souza, Marcelo Pasquini, Binod Dhakal
Published in Haematologica (2025-08-01)Get full text
Article -
7
Outcomes of VDPACE with an immunomodulatory agent as a salvage therapy in relapsed/refractory multiple myeloma with extramedullary disease by Al‐Ola Abdallah, Ghulam Rehman Mohyuddin, Nausheen Ahmed, Meera Mohan, Wei Cui, Leyla Shune, Zahra Mahmoudjafari, Joseph McGuirk, Siddhartha Ganguly, Shebli Atrash
Published in eJHaem (2021-11-01)Get full text
Article -
8
Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort study by Jing Dong, Zhuping Garacci, Christopher Staffi Buradagunta, Anita D’Souza, Meera Mohan, Ashley Cunningham, Siegfried Janz, Binod Dhakal, Aaron P. Thrift, Parameswaran Hari
Published in Blood Cancer Journal (2022-02-01)Get full text
Article -
9
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study by Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Rajshekhar Chakraborty, Leo Rasche, Carolina Schinke, Anita D’Souza, Meera Mohan
Published in Blood Cancer Journal (2024-03-01)Get full text
Article -
10
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review by Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira Mian, Luciano J. Costa, Douglas Sborov, Ghulam Rehman Mohyuddin
Published in Blood Cancer Journal (2024-01-01)Get full text
Article -
11
Real-world treatment patterns for teclistamab and talquetamab in multiple myeloma (MM): experience from 609 patients by Farheen Chunara, Chris Lugo, Kristen Osinski, Mansi R. Shah, Nishi Shah, Jessica Kent, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Gurbakhash Kaur, Rajshekhar Chakraborty, Rahul Banerjee, Leo Rasche, Carolina Schinke, Anita D’Souza, Aniko Szabo, Meera Mohan
Published in Blood Cancer Journal (2025-04-01)Get full text
Article -
12
Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma by Rajshekhar Chakraborty, Heloise Cheruvalath, Anannya Patwari, Aniko Szabo, Carolina Schinke, Binod Dhakal, Suzanne Lentzsch, Anita D’Souza, Ghulam Rehman Mohyuddin, Kelley Julian, Shonali Midha, Patrick Costello, Martin Kaiser, Melissa Ng Liet Hing, Simon J. Harrison, Edward R. Scheffer Cliff, Meera Mohan
Published in Blood Cancer Journal (2024-08-01)Get full text
Article -
13
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study by Meera Mohan, Jorge Monge, Nishi Shah, Danny Luan, Mark Forsberg, Vineel Bhatlapenumarthi, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Samer Al-Hadidi, Dennis Cooper, Suzanne Lentzsch, Frits van Rhee, Anita D’Souza, Aniko Szabo, Carolina Schinke, Rajshekhar Chakraborty
Published in Blood Cancer Journal (2024-03-01)Get full text
Article -
14
The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma by Lindsay Hammons, Aniko Szabo, Abhishek Janardan, Vineel Bhatlapenumarthi, Evanka Annyapu, Binod Dhakal, Samer Al Hadidi, Sabarinath Venniyil Radhakrishnan, Ravi Narra, Divaya Bhutani, Sharmilan Thanendrarajan, Siegfried Janz, Maurizio Zangari, Suzanne Lentzsch, Frits van Rhee, Juan Carlos Rico Crescencio, Anita D’Souza, Rajshekhar Chakraborty, Meera Mohan, Carolina Schinke
Published in Haematologica (2023-08-01)Get full text
Article -
15
Sustained disease remission after a limited duration of bispecific antibody therapy in patients with multiple myeloma by Gala Vega, Daniel Morillo, Christine Riedhammer, Febe Smits, Aishee Bag, Kelly Julian, Natalia Tovar Gomis, Carmen Montes Gaisan, Maria Aranzazu Bermudez, Mansi R. Shah, Ghulam Rehman Mohyuddin, Binod Dhakal, Leo Rasche, Carolina Schinke, Anita D'Souza, Aniko Szabo, Niels W. C. J. van de Donk, Rajshekhar Chakraborty, Meera Mohan
Published in HemaSphere (2026-06-01)Get full text
Article -
16
Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma by Meera Mohan, Aniko Szabo, Heloise Cheruvalath, Anna Clennon, Vineel Bhatlapenumarthi, Anannya Patwari, Metodi Balev, Divaya Bhutani, Asis Shrestha, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Anup Trikannad, Sruthi Vellanki, Samer Al-Hadidi, Suzanne Lentzsch, Frits van Rhee, Aishee Bag, Anita D’Souza, Nishi Shah, Rajshekhar Chakraborty, Mansi R. Shah, Carolina Schinke
Published in Blood Cancer Journal (2025-04-01)Get full text
Article -
17
Mindfulness vs. sleep education during autologous hematopoietic cell transplantation for multiple myeloma: Feasibility of a randomized controlled pilot study by Elisabeth C. Henley, Hannah A. Liphart, Keayra J. Morris, Iwalola Awoyinka, Michael R. Irwin, Erin S. Costanzo, Diana Winston, Anita D'Souza, Melinda Stolley, Binod Dhakal, Meera Mohan, Marcelo C. Pasquini, Steven W. Cole, Erin S. Doerwald, Peyton C. Bendis, Kelly E. Rentscher, Meredith E. Rumble, Aniko Szabo, Sridhar Rao, Jennifer M. Knight
Published in Contemporary Clinical Trials Communications (2025-10-01)Get full text
Article -
18
Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study by Doris K. Hansen, Danai Dima, Hira Mian, Jakob Devos, Ruta Brazauskas, Temitope Oloyede, Aimaz Afrough, Nausheen Ahmed, Larry Anderson, Rahul Banerjee, Jesus G. Berdeja, Aram Bidikian, Binod Dhakal, Ajoy Dias, Yvonne Efebera, Muhammad Salman Faisal, Lohith Gowda, Hamza Hashmi, Abu-Sayeef Mirza, Meera Mohan, Ravi Narra, Ashley E. Rosko, Mark Schroeder, Taiga Nishihori, Heather Landau, Saad Usmani, Marcelo C. Pasquini, Othman S. Akhtar, Surbhi Sidana, Krina K. Patel
Published in Blood Cancer Journal (2026-04-01)Get full text
Article -
19
The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype by Carolina Schinke, Antje Hoering, Hongwei Wang, Victoria Carlton, Sharmilan Thanandrarajan, Shayu Deshpande, Purvi Patel, Gabor Molnar, Sandra Susanibar, Meera Mohan, Pankaj Mathur, Muthukumar Radhakrishnan, Shadiqul Hoque, Jorge Jo Kamimoto, Monica Grazziutti, Frits van Rhee, Maurizio Zangari, Giovanni Insuasti-Beltran, Daisy Alapat, Ginell Post, Shmuel Yaccoby, Joshua Epstein, Leo Rasche, Sarah Johnson, Martin Moorhead, Tom Willis, Bart Barlogie, Brian Walker, Niels Weinhold, Faith E Davies, Gareth J. Morgan
Published in Haematologica (2017-08-01)Get full text
Article
